Healthy adults
Conditions
Interventions
The study food diluted with water or lukewarm water will be ingested in two divided doses, after breakfast and dinner.
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Age between 20 and 65 years at the time of informed consent 2.Healthy adults (those without serious organ disorders or specific diseases, those who have not received treatment). 3.Constipation as 2 to 5 times a week of week. 4.Those who are able to input electronic diary with smartphone / PC 5.Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate in the trial with written consent
Exclusion criteria
Exclusion criteria: 1.Those who has been currently visiting a hospital or treated with any drug or herbal remedy (however, dosing as needed is allowed) for any disease 2.On diet / exercise therapy under the guidance of a doctor 3.Have a current or history of serious illness 4.Are undergoing treatment for digestive disorders and constipation. 5.Have had gastrointestinal surgery (appendicitis is acceptable) 6.Take antiflatulent or laxatives daily 7.Take lactic acid bacteria drinks, yogurt or supplements containing lactic acid bacteria daily 8.Those who regularly ingest any food for specified health use, health food or supplement 9.Those who have a current or previous history of drug and/or food allergies 10.Planning to significantly change their lifestyle (diet, sleep, exercise, etc.) during the trial 11.Excessive consumption of alcohol (alcohol equivalent 60g or more / day) 12.Smokers (who have not been smoking for the last year) 13.Irregular diet, shift worker, night shift, irregular life rhythm 14.Those who are currently pregnant or breastfeeding or those who want to become pregnant during the test period 15.Participation in another clinical trial within one month of enrollment into the trial, participating currently or planning to participate 16.Those who were determined by the investigator to be unsuitable for participation in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| frequency and amount of stool,type of stool, conditions at defecation | — |
Secondary
| Measure | Time frame |
|---|---|
| Fecal microflora | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed